Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

THE OPPORTUNITY:

To aid in this mission, the Translational Medicine team at RevMed is seeking a highly motivated, scientifically creative, and collaborative Senior Director to work in a fast-paced environment within a cross-functional team. This role will report to the Head of Translational Medicine (TM) and be leading a group of TM biomarker scientists to design and execute clinical biomarker plans for multiple RAS(ON) inhibitor clinical programs across solid cancer types. The position will serve as a subject-matter expert (SME) in clinical biomarker development and support clinical development strategy and programs through product life cycle.

REQUIRED EXPERIENCE, SKILLS, AND EDUCATION:

A Ph.D. in cancer biology, cell/molecular biology, genomics or equivalent with 10+ years of industry experience.
6+ years of experience in clinical biomarker development in oncology is required.
Broad knowledge and understanding of established and novel technologies employed in clinical diagnostic assays (e.g. NGS, IHC, PCR) are required.
Excellent scientific and business communication skills, strong interpersonal/collaboration skills and planning skills.
Ability to think critically and creatively and be able to work independently to determine appropriate resources for resolution of problems.
Ability to multi-task and thrive in a fast-paced innovative environment.
A great teammate, who listens effectively and invites response and discussion.
Commitment to Revolution Medicines’ Core Values: Tireless Commitment to Patients, Transformative Science, Exceptional Together, Total Integrity, Inclusiveness and Fairness.

PREFERRED EXPERIENCE, SKILLS, AND EDUCATION:

Knowledge of RAS biology and mechanism of action of RAS inhibitors is preferred.
The base salary range for this full-time position is $235,000 to $281,000 for candidates based at our headquarters in Redwood City, CA. The range displayed on each job posting is intended to be the minimum and maximum salary for the position in Redwood City and will be adjusted for the local market a candidate is based. Our salary ranges are determined by role, level, and location. Individual pay is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base salary is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.

LI-Hybrid #LI-SH

Lead strategic, translational thinking and contributions to early and late-stage clinical development plans.
Represent Translational Medicine function on cross-functional teams at program level.
Effectively collaborate with Clinical Development, Clinical Operations, Biostatistics, Biomarker Operations, and Regulatory on study design and protocol development.
Lead biomarker scientists in formulating clinical biomarker strategies and partner with clinical bioinformaticians in developing biomarker analysis plans, as well as effectively collaborate with TM subfunctions of Biomarker Operations, Clinical Bioinformatics, and Companion Diagnostics.
Collaborate with Clinical Development, Biostatistics, and Medical Affairs to develop plans for publication of clinical biomarker results.
Collaborate with Cancer Biology, Translational Research, and Cancer Immunology to accelerate forward and reverse translational research.
Keep abreast in new developments in RAS biology, predictive biomarkers, and novel molecular assays, and share knowledge with functional and cross-functional team members.